Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $155506.0.

  • iSpecimen's Current Deferred Revenue fell 4516.15% to $155506.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $155506.0, marking a year-over-year decrease of 4516.15%. This contributed to the annual value of $360708.0 for FY2024, which is 1324.36% down from last year.
  • iSpecimen's Current Deferred Revenue amounted to $155506.0 in Q3 2025, which was down 4516.15% from $164066.0 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Current Deferred Revenue peaked at $802860.0 during Q2 2021, and registered a low of $46910.0 during Q3 2023.
  • Moreover, its 5-year median value for Current Deferred Revenue was $272681.0 (2024), whereas its average is $330971.4.
  • Per our database at Business Quant, iSpecimen's Current Deferred Revenue plummeted by 8278.66% in 2023 and then soared by 50450.01% in 2024.
  • Quarter analysis of 5 years shows iSpecimen's Current Deferred Revenue stood at $654746.0 in 2021, then plummeted by 79.79% to $132335.0 in 2022, then surged by 214.18% to $415771.0 in 2023, then fell by 13.24% to $360708.0 in 2024, then crashed by 56.89% to $155506.0 in 2025.
  • Its last three reported values are $155506.0 in Q3 2025, $164066.0 for Q2 2025, and $270208.0 during Q1 2025.